Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.
Abizanda P, Calbo Mayo JM, Mas Romero M, Cortés Zamora EB, Tabernero Sahuquillo MT, Romero Rizos L, Sánchez-Jurado PM, Sánchez-Nievas G, Campayo Escolano C, Ochoa Serrano A, Sánchez-Flor Alfaro V, López Bru R, Gómez Ballesteros C, Caldevilla Bernardo D, Callejas González FJ, Andrés-Pretel F, Lauschke VM, Stebbing J.
Abizanda P, et al.
J Am Geriatr Soc. 2021 Oct;69(10):2752-2758. doi: 10.1111/jgs.17357. Epub 2021 Jul 9.
J Am Geriatr Soc. 2021.
PMID: 34235720
Free PMC article.